Business
Board Changes
Porvair PLC announced board changes effective October 1, 2025, with the appointment of Lisa Anson as a Non-Executive Director. Anson will join the Audit, Remuneration, and Nomination Committees. Sally Martin, having served for 9 years, will retire from the Board on November 4, 2025. Following Martin's retirement, Sheena Mackay will be appointed Senior Independent Director and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee. Disclaimer*
About this update from Porvair Plc
[{"type":"text","content":"\n\n \nFor immediate release 25 September 2025\n \n\n \nPorvair plc\n(\"Porvair\" or the \"Group\" or the \"Company\")\n \nBoard Changes\nLisa Anson\nLisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025.\nLisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI).\nLisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland.\nOn appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair.\nPorvair confirms that there are no further matters in relation to Lisa Anson's appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.\nSally Martin\nHaving completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025.\nSheena Mackay\nFollowing Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.\nFor further information, please contact:\n\n\n\n\nPorvair plc\n\n\n+44 (0)1553 765 500\n\n\n\n\nHooman Caman Javvi, Chief Executive O...